NUDT15 and cancer: The protein trajectory was assessed based on RMSD, RMSF, RG, SASA, and HB to determine structural characteristics of NUDT15 wild-type and the variants (Val18Ile, Arg139Cys, and Arg139His) with the three anti-cancer drugs (Table 4).